சாவை மனிதன் சிங் மருத்துவ கல்லூரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சாவை மனிதன் சிங் மருத்துவ கல்லூரி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சாவை மனிதன் சிங் மருத்துவ கல்லூரி Today - Breaking & Trending Today

Explained: What has led to a crippling shortage of Remdesivir used in Covid treatment | India News


NEW DELHI: Amid an unprecedented surge in fresh Covid-19 infections, multiple states, including Maharashtra, Gujarat and Delhi, have flagged a shortage of anti-viral drug Remdesivir. The shortage prompted the government to halt the export of the drug and Remdesivir active pharmaceutical ingredients (APIs) till the Covid spread is contained.
As the country witnesses a ferocious resurgence of the virus, so has the demand for this medicine. Here are a few questions answered on the use of Remdesivir for Covid treatment and problems in the supply chain management.
How did Remdesivir come into use?
Remdesivir is an investigational antiviral drug to fight Sars-Cov 2, the virus that causes Covid-19. The US Food and Drug Administration (FDA) approved Gilead Sciences Inc’s antiviral therapy Remdesivir in October 2020, making it the first drug to obtain formal clearance for treating the coronavirus disease. ....

United States , Biocon Syngene , Zydus Cadila , Mansukh Mandavia , Gilead Sciences , World Health Organization , Drug Administration , Gilead Sciences Inc , Jubilant Life Sciences , Sawai Man Singh Medical College , National Clinical Management Protocol For Covid , Us National Institutes Of Health , National Clinical Management Protocol , Injection Remdesivir , Hetero Labs , Zydus Cadila Healthcare , Remdesivir Active Pharmaceutical Ingredients , India News , India News Today , Today News , Google News , Breaking News , Reddys Laboratories , Department Of Pharmaceuticals , Covid 19 , ஒன்றுபட்டது மாநிலங்களில் ,